Observational studyAdvances in therapy2023

Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study.

Bruce H R Wolffenbuttel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.